Other chemokines and cytokines known to be involved in glioma progression, such as CCL2, CXCL10 and IL-6, are selectively upregulated in the glioma-bearing hemisphere, and these increases are strongly reduced in EE mice (Table 1). The gene discussed is CXCL10; the disease is central nervous system cancer.